Back to Search Start Over

A0752 - Identification of resistance mechanisms to evaluate therapeutic options for refractory yolk-sac tumors using multikinase inhibitors or antibody (CLDN6)-/ nanobody (CXCR4)-drug-conjugates.

Authors :
Skowron, M.A.
Bremmer, F.
Kotthoff, M.
Ruhnke, K.
Wakileh, G.A.
Bierholz, P.
Stephan, A.
Parmaksiz, F.
Che, Y.
Pauls, S.
Stefanski, A.
Anbuhl, S.
Heukers, R.
Smit, M.J.
Stühler, K.
Albers, P.
Nettersheim, D.
Source :
European Urology. Feb2023:Supplement 1, Vol. 83, pS1063-S1064. 2p.
Publication Year :
2023

Subjects

Subjects :
*CXCR4 receptors
*IMMUNOGLOBULINS
*TUMORS

Details

Language :
English
ISSN :
03022838
Volume :
83
Database :
Academic Search Index
Journal :
European Urology
Publication Type :
Academic Journal
Accession number :
161555124
Full Text :
https://doi.org/10.1016/S0302-2838(23)00793-5
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details